Coherus Oncology
CHRS
CHRS
188 hedge funds and large institutions have $1.54B invested in Coherus Oncology in 2020 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 65 increasing their positions, 55 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
9% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 45
32% less call options, than puts
Call options by funds: $1.73M | Put options by funds: $2.53M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
188
Holding in Top 10
2
Calls
$1.73M
Puts
$2.53M
Top Buyers
| 1 | +$85.2M | |
| 2 | +$39.3M | |
| 3 | +$29.9M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$19.8M |
| 5 |
RI
Redwood Investments
Boston,
Massachusetts
|
+$16M |
Top Sellers
| 1 | -$32.8M | |
| 2 | -$25.7M | |
| 3 | -$11.7M | |
| 4 |
HP
Hound Partners
New York
|
-$10.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$10.7M |